Literature DB >> 12526018

Detection of apolipoprotein E phenotype in unconcentrated cerebrospinal fluid.

P D Mehta1, B A Patrick, T Pirttila, P K Coyle, P S Aisen.   

Abstract

We developed a simple method to detect apolipoprotein E (Apo E) polymorphism distribution in approximately 20 microL of unconcentrated cerebrospinal fluid (CSF). A combination of isoelectric focusing in 3 M urea gel and immunoblotting was employed. Apo E phenotypes were identified in CSF samples from 45 patients with probable Alzheimer disease (AD), 15 with multiple sclerosis (MS), and 25 with other neurological diseases (OND). When the data were compared with a set of matched plasma samples, the results were identical. The method is useful for Apo E phenotyping from fresh or frozen unconcentrated CSF, when blood or plasma is not available. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12526018      PMCID: PMC6807740          DOI: 10.1002/jcla.10063

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  24 in total

1.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

2.  Standardized determination of apolipoprotein E phenotypes by simplified isoelectric focusing/immunoblotting in plasma and synovial fluid.

Authors:  A K Adiloglu; A Gurakur-Osborne; P E Prete
Journal:  Clin Chim Acta       Date:  1998-05-08       Impact factor: 3.786

3.  Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

Authors:  R Mayeux; A M Saunders; S Shea; S Mirra; D Evans; A D Roses; B T Hyman; B Crain; M X Tang; C H Phelps
Journal:  N Engl J Med       Date:  1998-02-19       Impact factor: 91.245

4.  Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotype.

Authors:  S Kataoka; M Paidi; B V Howard
Journal:  Clin Chem       Date:  1994-01       Impact factor: 8.327

5.  Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease.

Authors:  Guomei Tang; Huijun Xie; Lin Xu; Yixin Hao; Dayu Lin; Daming Ren
Journal:  Am J Med Genet       Date:  2002-05-08

6.  Association of the APOE epsilon4 allele with disease activity in multiple sclerosis.

Authors:  N Evangelou; M Jackson; D Beeson; J Palace
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

7.  Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apolipoprotein E polymorphism.

Authors:  M I Kamboh; R E Ferrell; B Kottke
Journal:  J Lipid Res       Date:  1988-11       Impact factor: 5.922

Review 8.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Authors:  R W Mahley
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

9.  Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.

Authors:  T Lehtimäki; T Pirttilä; P D Mehta; H M Wisniewski; H Frey; T Nikkari
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

10.  No association between the APOE epsilon4 allele and outcome and susceptibility in primary progressive multiple sclerosis.

Authors:  S J Weatherby; C L Mann; A A Fryer; R C Strange; C P Hawkins; V L Stevenson; S M Leary; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

View more
  1 in total

1.  The relationship of plasma Abeta levels to dementia in aging individuals with Down syndrome.

Authors:  Yasuji Matsuoka; Howard F Andrews; Amanda G Becker; Audrey J Gray; Pankaj D Mehta; Mary C Sano; Arthur J Dalton; Paul S Aisen
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.